Health

    Chronic & Non Communicable Diseases

    Medical Treatment & Drug Development

    Metabolic Health, Diabetes & Obesity

    Vaccines

    Biotech- and Nanotechnology

Ph.D

Canada

2010.09.30

Re-establishing self-tolerance by targeting MHC class II-restricted autoimmunity

Juvenile diabetes is an autoimmune disease resulting from an attack that destroys pancreatic cells that secrete insulin. Javier Clemente Casares is studying a therapeutic approach that could lead to a nanovaccine for the disease.

A nanovaccine for juvenile diabetes

To add or modify information on this page, please contact us at the following address: community.research@axa.com

Javier
CLEMENTE-CASARES

Institution

University of Calgary

Country

Canada

Nationality

Spanish

Related articles

Health

Chronic & Non Communicable Diseases

Medical Treatment & Drug Development

Chronic Pain & Musculoskeletal Disorders

Drug Delivery

Biotech- and Nanotechnology

AXA Project

France

Pain Pediatric & Elderly AXA Research Lab (PEARL)

Chronic pain is recognized as a major public health problem affecting patients in their daily activity, physical and mental health,... Read more

Celine
GRECO

Hôpital Necker-Enfants Malades

Health

Medical Treatment & Drug Development

Drug Delivery

Biotech- and Nanotechnology

Mécénat des Mutuelle

France

Accelerating drug innovation with the Euridis school and its DDD Challenge

The project addresses a dual challenge: on one hand, the increasing complexity of drug development, which requires a thorough understanding... Read more

Laurence
SABATIER

Institut du médicament de Strasbourg

Health

Women's Health

Chronic & Non Communicable Diseases

Prevention & Personalised Health

Reproductive Health & Menopause

Stroke & Cardiovascular Diseases

Genetics & Omics

Immune System

AXA Chair

Spain

2024.02.02

Understanding Menopause's Effect on Women's Cardiovascular Risk

Cardiovascular disease (CVD) is the leading cause of mortality for women worldwide, yet women remain understudied. Atherosclerosis, the main pathology... Read more

Inés
PINEDA-TORRA

University of Seville